2232 - Association between Inappropriate Empiric Therapy (IET) and 30-Day Emergency Department/Inpatient (ED/IP) Visits Among Adult Outpatients (OPs) with Complicated Urinary Tract Infections (cUTIs)

Saturday, October 22, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

LC

Lie Hong H. Chen, DrPH, MSPH

Biostatistician
Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, United States
KB

Katia J. Bruxvoort, PhD, MPH

University of Alabama at Birmingham
Birmingham, Alabama, United States
RW

Rong Wei, MA

Programmer
Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, United States
TI

Theresa M. Im, MPH

Research Project Manager
Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, United States
RC

Richard Contreras, MS

Kaiser Permanente Southern California Department of Research & Evaluation
Pasadena, California, United States
Mauricio Rodriguez, PharmD, MS-HEOR, BCPS, BCCCP, BCIDP

Senior Director, Health Economics Outcomes Research (HEOR)
Spero Therapeutics (Former Employee)
San Antonio, TX, United States
LF

Larry Friedrich, PharmD

Spero Therapeutics
Cambridge, Massachusetts, United States
JR

Jennifer Reese, PharmD

Vice President, Medical Affairs
Spero Therapeutics
Cambridge, Massachusetts, United States
ST

Sara Y. Tartof, PhD MPH

Epidemiologist/Research Scientist I
Kaiser Permanente Southern California
Pasadena, California, United States